Health Care & Life Sciences » Pharmaceuticals | Miraca Holdings Inc.

Miraca Holdings Inc. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
26,130
24,331
3,598
4,438
7,083
11,375
Depreciation, Depletion & Amortization
14,716
15,370
14,993
13,122
9,638
9,704
Other Funds
67
98
99
95
74
4,051
Funds from Operations
30,739
28,017
31,309
36,577
16,482
25,130
Changes in Working Capital
2,016
1,244
1,993
141
715
8,886
Net Operating Cash Flow
28,723
29,261
29,316
36,436
15,767
16,244
Capital Expenditures
9,521
13,951
12,270
8,154
17,294
Sale of Fixed Assets & Businesses
-
2,370
-
-
-
Purchase/Sale of Investments
-
15,447
-
516
874
Net Investing Cash Flow
17,153
27,874
11,965
8,599
21,552
Cash Dividends Paid - Total
5,027
5,220
5,742
6,374
6,951
Issuance/Reduction of Debt, Net
5,237
4,963
6,629
16,814
2,749
Net Financing Cash Flow
9,699
9,980
12,115
23,138
9,635
Net Change in Cash
2,817
8,382
4,456
3,803
15,103
Free Cash Flow
22,409
22,139
23,614
32,052
1,010
Net Assets from Acquisitions
7,964
-
-
-
2,277
Other Sources
332
143
305
91
-
Change in Capital Stock
632
9,625
355
147
141
Exchange Rate Effect
946
211
780
896
317
Other Uses
-
989
-
1,051
1,103

About Miraca Holdings

View Profile
Address
Shinjuku Mitsui Building, 8/F
Tokyo Tokyo 163
Japan
Employees -
Website http://www.miraca-holdings.co.jp
Updated 07/08/2019
Miraca Holdings Inc. operates as a holding company which provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: In Vitro Diagnostics, Clinical Laboratory Testing, and Healthcare Related. The In Vitro Diagnostic segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back.